The Metro Health System Main Campus

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Lupus (SLE)
• Rheumatoid arthritis

Running trials

• Recruiting

  A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

  NCT06570798· Phase 2· Amgen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lupus (SLE)1 recruiting
• Rheumatoid arthritis1 recruiting